News | Atrial Fibrillation

Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...

Home November 19, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | HIMSS

The deadline for early bird discounts for HIMSS25 is rapidly approaching. Register by December 15 to save up to $500 on ...

Home November 15, 2024
Home
News | Cardiac Imaging

Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing ...

Home November 13, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Atherectomy Devices

Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular ...

Home November 08, 2024
Home
News

Nov. 1, 2024 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co. recently announced U.S. Centers ...

Home November 08, 2024
Home
News

Nov, 4, 2024 – R3 Vascular Inc. has announced that the U.S. Food and Drug Administration (FDA) granted investigational ...

Home November 07, 2024
Home
News | Intra-Vascular Ultrasound (IVUS)

Oct. 28, 2024 — Cardiawave SA, developer of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for treating severe ...

Home November 07, 2024
Home
News | Thrombectomy Devices

Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...

Home November 07, 2024
Home
News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News | FFR Technologies

Oct. 27, 2024 — HeartFlow, Inc. recently announced seven-year data confirming the use of HeartFlow’s AI-enabled ...

Home October 30, 2024
Home
News | Artificial Intelligence

Oct. 30, 2024 — HeartLung Technologies, a developer of AI tools for early detection of heart disease, lung cancer and ...

Home October 30, 2024
Home
News

Impella ECP pump insertion. Oct. 28, 2024 — Results from the first completed pivotal trial on patients supported with ...

Home October 29, 2024
Home
Subscribe Now